CNVIF (Conavi Medical) LT-Debt-to-Total-Asset: 1.18 (As of Mar. 2026)


CNVIF Conavi Medical Corp CNVIF
4 GF Score
Price $0.17
! 5 Warning Signs
View Full Analysis

What is Conavi Medical LT-Debt-to-Total-Asset?

Conavi Medical CNVIF 4 LT-Debt-to-Total-Asset is 1.18 as of Mar. 2026. GuruFocus rates CNVIF with a GF Score™ of 4/100. The stock has 5 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Conavi Medical's long-term debt to total assests ratio for the quarter that ended in Mar. 2026 was 1.18.

Conavi Medical's long-term debt to total assets ratio declined from Mar. 2025 (2.79) to Mar. 2026 (1.18). It may suggest that Conavi Medical is progressively becoming less dependent on debt to grow their business.

Conavi Medical  (OTCPK:CNVIF) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Conavi Medical LT-Debt-to-Total-Asset Related Terms

Conavi Medical LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Conavi Medical's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Conavi Medical LT-Debt-to-Total-Asset Chart

Conavi Medical Annual Data
Trend Sep24 Sep25
LT-Debt-to-Total-Asset
2.99 1.45

Conavi Medical Quarterly Data
Sep23 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only 2.79 1.04 1.45 1.72 1.18
CNVIF
4GF Score
Conavi Medical Corp CNVIF
LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Conavi Medical LT-Debt-to-Total-Asset Calculation

Conavi Medical's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Sep. 2025 is calculated as

LT Debt to Total Assets (A: Sep. 2025 )=Long-Term Debt & Capital Lease Obligation (A: Sep. 2025 )/Total Assets (A: Sep. 2025 )
=13.011/8.995
=1.45

Conavi Medical's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (Q: Mar. 2026 )=Long-Term Debt & Capital Lease Obligation (Q: Mar. 2026 )/Total Assets (Q: Mar. 2026 )
=12.327/10.432
=1.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 1.18 mean?
Conavi Medical (CNVIF) has a LT-Debt-to-Total-Asset of 1.18 as of Mar. 2026. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Conavi Medical and its competitors.
Is Conavi Medical's LT-Debt-to-Total-Asset too high?
Conavi Medical's current LT-Debt-to-Total-Asset is 1.18. Overall, Conavi Medical has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Conavi Medical's LT-Debt-to-Total-Asset compare to ABT and SYK?
Conavi Medical's LT-Debt-to-Total-Asset of 1.18 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Medical Devices & Instruments company?
A good LT-Debt-to-Total-Asset depends on the Medical Devices & Instruments industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Conavi Medical and its competitors. Conavi Medical's current LT-Debt-to-Total-Asset is 1.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Conavi Medical stock overvalued right now?
Conavi Medical (CNVIF) has a current LT-Debt-to-Total-Asset of 1.18. The current LT-Debt-to-Total-Asset is 1.18. Conavi Medical's overall GF Score™ is 4/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Conavi Medical (CNVIF), the current LT-Debt-to-Total-Asset is 1.18 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Conavi Medical Business Description

Other Exchanges CNVI:Canada
Address 293 Lesmill Road, Toronto, ON, CAN, M3B 2V1
Conavi Medical Corp is focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. Its Novasight Hybrid System is the first system to combine both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) to enable simultaneous and co-registered imaging of coronary arteries.
4GF Score

Get the complete analysis for CNVIF

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.17
Price